GlassScriptPhysician profile
Jefrey Ralph Alan Fishman
NPI 1144238593
$4,576.46
in general payments reported to CMS, 2019-2025
21 companies · $1,488 in 2025
The $1,488 reported for 2025 was more than what 80% of Surgery of The Hand (Plastic Surgery) providers received nationally (typical 2025 total: $312).
See the full distribution for Surgery of the Hand (Plastic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $499 · 2020: $556 · 2021: $552 · 2022: $475 · 2023: $593 · 2024: $414 · 2025: $1,488.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,494.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $496.71 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Axogen | $453.07 | 2019-2025 | |
| Abbvie INC. | $387.57 | 2023-2025 | |
| Allergan, INC. | $381.57 | 2019-2022 | |
| Polynovo North America LLC | $338.78 | 2023-2025 | Novosorb Btm |
| Mentor Worldwide LLC | $314.17 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Kerecis Limited | $311.22 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Sientra, INC. | $305.28 | 2021-2022 | |
| Depuy Synthes Sales INC. | $255.91 | 2020-2024 | Trumatch, Na, Cementralizer |
| Revance Therapeutics, INC. | $187.44 | 2024-2025 | Daxxify |
| Solventum Corporation | $170.89 | 2025 | Prevena |
| Stryker Corporation | $151.20 | 2020-2021 | |
| Medtronic, INC. | $137.73 | 2023-2025 | V-Loc 180 |
| Galderma Laboratories, L.P. | $120.72 | 2020-2023 | Dysport |
| Acell, INC. | $112.74 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $111.89 | 2021 | |
| Tela Bio, INC. | $98.62 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Kls-Martin L.P. | $89.99 | 2020-2021 | |
| Avita Medical Americas, LLC | $86.28 | 2025 | Permeaderm, Recell, Cohealyx |
| Baxter Healthcare | $44.76 | 2025 | Artiss |
| Mimedx Group, INC. | $19.92 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jefrey Fishman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.